Tebentafusp – sold under the brand name Kimmtrak – is the first treatment of its kind for uveal melanoma, which develops from ...

In Morbidity and Mortality Weekly Report, three new studies describe increased infections of parvovirus B19 detected in US ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. Type 1 diabetes develops when the body destroys its own insulin-producing cells.

Something is blooming above the Parnassus Heights campus – where scientists are accelerating research to treat the world’s ...

Join Lalla Hirayama in her call to action as she delves into her health journey, tackling the stigma around Pap smears and ...

The U.S. Food and Drug Administration gave SC291, a CD19-directed allogeneic CAR T cell therapy developed using Sana's hypoimmune platform, fast track designation, a process designed to facilitate the ...

NFL legend Randy Moss has called upon his fans for prayers after concerns were raised about his eye color. On December 1, the ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other ...

The original pandemic virus before it was supplanted by SARS-CoV-2 is still influenza. Over the centuries, influenza pandemics have decimated human populations. One of the worst in history is the 1918 ...

Hundreds of eligible patients will need to pay thousands of dollars out of pocket to access a cutting-edge treatment after ...